research use only

4-Vinylcyclohexene dioxide

Cat.No.E0024

4-Vinylcyclohexene dioxide (Vinylcyclohexene dioxide, VCD) is a chemical used to induce menopause and decrease estrogen production. This compound is used as a crosslinking agent for the production of epoxy resins.
4-Vinylcyclohexene dioxide Chemical Structure

Chemical Structure

Molecular Weight: 140.18

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 140.18 Formula

C8H12O2

Storage (From the date of receipt) 2 years 4°C liquid
CAS No. 106-87-6 -- Storage of Stock Solutions

Synonyms Vinylcyclohexene dioxide, VCD Smiles C1CC2OC2CC1C3CO3

Solubility

In vitro
Batch:

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06173115 Recruiting
Severe Aortic Stenosis
Second Affiliated Hospital School of Medicine Zhejiang University
October 20 2023 Not Applicable
NCT05335525 Recruiting
Vascular Closure|Endovascular Procedure|Hemostasis|Peripheral Vascular Disease|Femoral Artery
Terumo Europe N.V.|Terumo Medical Corporation
September 30 2022 --
NCT04656951 Recruiting
Multiple Myeloma
University of Cologne|Janssen-Cilag G.m.b.H
June 1 2021 Phase 2
NCT04459208 Completed
Aortic Valve Stenosis
Helios Health Institute GmbH
June 26 2020 Not Applicable

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.